Cardiovascular drugs

被引：2

|

作者：

不详

机构：

来源：

DRUG NEWS & PERSPECTIVES | 2004年 / 17卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：201 / 201

页数：1

相关论文

共 50 条

[41] Interaction of anticoagulants and cardiovascular drugs
Ludwig, HC
INTERNIST, 1998, 39 (05): : 531 - 532
[42] Cardiovascular drugs and the elderly.
Grand, A
ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1997, 46 (07): : 461 - 468
[43] Allergy/Respiratory and Cardiovascular Drugs
Schweitzer, Paula K.
SLEEP MEDICINE CLINICS, 2010, 5 (04) : 541 - 557
[44] CARDIOVASCULAR RESUSCITATION DRUGS FOR CHILDREN
HOLBROOK, PR
MICKELL, J
POLLACK, MM
FIELDS, AI
CRITICAL CARE MEDICINE, 1980, 8 (10) : 588 - 589
[45] UPDATE ON CARDIOVASCULAR DRUGS AND ELDERS
REDEKER, NS
AMERICAN JOURNAL OF NURSING, 1995, 95 (09) : 34 - 41
[46] Diabetes Drugs and Cardiovascular Safety
Bae, Ji Cheol
ENDOCRINOLOGY AND METABOLISM, 2016, 31 (02) : 239 - 244
[47] Gender Differences in Cardiovascular Drugs
Amanda J. Stolarz
Nancy J. Rusch
Cardiovascular Drugs and Therapy, 2015, 29 : 403 - 410
[48] Capillary electrophoresis of cardiovascular drugs
Nguyen, NT
Siegler, RW
JOURNAL OF CHROMATOGRAPHY A, 1996, 735 (1-2) : 123 - 150
[49] Sulfonylurea drugs and cardiovascular mortality
O'Keefe, JH
McCallister, BD
Blackstone, EH
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (03) : 958 - 958
[50] Cardiovascular safety of diabetes drugs
Ozerlat-Gunduz, Iley
LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (02): : 92 - 92

← 1 2 3 4 5 →